Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:2765-2768
Published online before print July 17, 2008, doi: 10.1161/STROKEAHA.107.512269
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/10/2765    most recent
STROKEAHA.107.512269v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaudinski, M. R.
Right arrow Articles by Latour, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudinski, M. R.
Right arrow Articles by Latour, L. L.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Pathology of Stroke
Right arrowRelated Article

(Stroke. 2008;39:2765.)
© 2008 American Heart Association, Inc.


Original Contributions

Establishing Final Infarct Volume

Stroke Lesion Evolution Past 30 Days Is Insignificant

Martin R. Gaudinski, BA; Erica C. Henning, PhD; Aaron Miracle, BS; Marie Luby, PhD; Steven Warach, MD, PhD Lawrence L. Latour, PhD

From Section on Stroke Diagnostics and Therapeutics Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.

Correspondence to Lawrence L. Latour, PhD, Section on Stroke Diagnostics and Therapeutics, Stroke Branch, National Institute of Neurological Disorders and Stroke, Building 10, Room B1D733, 10 Center Drive, MSC 1063, Bethesda, MD 20892. E-mail latourl{at}ninds.nih.gov

Background and Purpose— Lesion volume measured on MRI has been used as an objective surrogate marker for outcome in clinical trials. However, lesion volumes vary over time because of edema and tissue loss. This study aims to determine if lesion volumes measured at 30 and 90 days after ictus significantly differ.

Methods— We performed a retrospective study of 18 patients who had acute (<24 hours) DWI and follow-up fluid-attenuated inversion recovery imaging at 5, 30, and 90 days. Two expert readers segmented lesions and the mean volumes of both reads were used in all statistical analyses.

Results— Patient age was 65.8 (SD, 13.7) years and median NIHSS at baseline was 11.5. Inter-rater variability for lesion volume measurements was 3.7 (5.8) mL. Acute DWI volume was 19.3 (17.3) mL. Fluid-attenuated inversion recovery volumes for 5, 30, and 90 days were 34.3 (23.5), 18.6 (14.0), and 15.9 (13.8) mL, respectively. These volumes differed significantly (P<0.001). Linear regression revealed a strong correlation (r=0.96; P<0.001) between lesion volumes at 30 and 90 days with a slope that did not vary significantly from 1.0 (P=0.448).

Conclusions— Lesions continue to evolve between 5 and 90 days, but by 30 days lesion volume approaches final infarct volume. While clinical response is the most meaningful outcome measure, our findings suggest that lesion volumes measured at 30 days may provide a sufficient approximation for final infarct volume for use in early phase clinical trials.


Key Words: final infarct volume • fluid-attenuated inversion recovery • lesion volume evolution • magnetic resonance imaging • stroke


Related Article:

Establishing Final Infarct Volume: Stroke Lesion Evolution Past 30 Days Is Insignificant
Peter D. Schellinger and Jochen B. Fiebach
Stroke 2008 39: 2693-2694. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
J. L. Saver, G. W. Albers, B. Dunn, K. C. Johnston, M. Fisher, and for the STAIR VI Consortium
Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke, July 1, 2009; 40(7): 2594 - 2600.
[Abstract] [Full Text] [PDF]